RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksNov 28 09:47 · Ratings

Why Is Biogen Inc. (BIIB) Among the Worst Performing Healthcare Stocks in 2024?

Yahoo FinanceNov 27 22:15

Trump Taps Jay Bhattacharya to Lead National Institutes of Health

Seeking AlphaNov 27 19:23

"LEQEMBI" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea

BiogenNov 27 13:00

Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials Driving The Negative Sentiment?

Simply Wall StNov 26 22:53

Anavex Gains After Seeking EU Marketing Nod for Alzheimer's Drug

Seeking AlphaNov 26 21:55